Background: Patients infrequently disclose use of dietary supplements to providers. Little is
known about factors that motivate patients to disclose supplement use. The study aimed to …

Despite increasing recognition of potential untoward interactions between herbal products
and conventional medications, a standard system for prospective assessment of these …

Objective Explore patterns in patients' disclosures of supplement use and identify provider
and patient characteristics associated with disclosures. Methods Cross-sectional study of 61 …

Traditional Chinese medicine (TCM) formulas with fixed combinations rely on" sovereign,
minister, assistant and guide" and fuzzy mathematical quantitative law, leading to greater …

Women at high risk of developing breast cancer are prescribed selective estrogen response
modulators, including raloxifene, as chemoprevention. Patients often seek complementary …

Purpose This study aimed to investigate the potential pharmacokinetic interactions between
curcumin, imatinib and bosutinib, combining In Vitro and in silico methods. Methods In Vitro …

Background Pregnant women's disclosure of herbal medicine (HM) use to their health care
providers during pregnancy is crucial, as misuse of HM can have a detrimental effect on both …

Despite the rich armamentarium of available drugs against different forms of cardiovascular
disease (CVD), major challenges persist in their safe and effective use. These include high …

Herbal medicines have been perceived as natural, safe, and economically and socio-
culturally acceptable remedies to many illnesses. Complementary and alternative medicine …

Breast cancer treatment by the aromatase inhibitor Letrozole (LET) or Selective Estrogen
Receptor Modulator Tamoxifen (TAM) can result in the onset of menopausal symptoms …